About the ALTG

DOWNLOAD our research report:

The Australasian Lung Cancer Trials Group Research Report 2014 – 2016

The Australasian Lung Cancer Trials Group (ALTG) is a core pillar of Lung Foundation Australia’s research strategy. The group was formed in 2004 and is Australia and New Zealand’s lung and thoracic cancer clinical research group. The ALTG is a multi-disciplinary organisation dedicated to reducing the incidence, morbidity and mortality of lung and other thoracic cancers and improving the quality of life of these patients, carers and families in Australia and New Zealand through the coordination and facilitation of high quality clinical research.

The ALTG collaborates with a number of organizations including the NHMRC Clinical Trials Centre (CTC) and Peter MacCallum Cancer Centre. Both of these groups are leaders in Australia for the design, conduct, analysis and publication of oncology clinical trials, including working with both Australia and international collaborative groups.

The specific objectives of the ALTG are:

  • To facilitate participation in the development, conduct, evaluation, reporting of clinical trials in lung and thoracic cancer.
  • To promote the use of clinical trials in evaluating new treatments and management approaches for lung and thoracic cancer.
  • To contribute to the translation of clinical trial findings into clinical practice.

Lung Foundation Australia

Lung Foundation Australia is a not-for-profit, public benevolent institution, launched in 1990 by a group of Physicians.
The Lung Foundation’s vision is to “ensure lung health is a priority for all in Australia”

The Lung Foundation is committed to reducing the prevalence and impact of lung cancer. It is a challenge that will require a collaborative effort from the community, research institutions, health professionals, government and other stakeholders. In order to influence health outcomes, the effort to combat lung cancer will have to be sustained and it is likely to be costly. However, the cost of inaction, both individually and for the community, mandates this concerted approach.

Lung Foundation Australia is proud of the achievements in recent years and has grown from small beginnings and is now responsible for a diverse range of initiatives, examples of which can be viewed via the Foundation’s website –www.lungfoundation.com.au

Lung Cancer National Program

Lung Foundation Australia’s Lung Cancer National Program works with our communities to reduce the impact of lung cancer and plays a lead role in improving outcomes for patients, carers, families and the community we serve.

The Lung Cancer National Program consists of three main initiatives which are the Lung Cancer National Program Group (LCNP), the Australasian Lung Cancer Trials Group (ALTG), Lung Cancer Network Australia (LCNA) and the Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF). These groups work independently.

The Lung Cancer National Program’s (LCNP, ALTG, LCNA, ANZ-LCNF ) Business Objectives are to:

  • Develop and provide information, coordinate and participate in educational programs relating to the prevention, detection, treatment and management of lung cancer and Mesothelioma.
  • Lung and thoracic cancer research, research into the causation, prevention and treatments.
  • Develop, promote, provide and coordinate services and resources for patients, their family members and carers.

Key Drivers for other initiatives within the Lung Cancer National Program are:

Lung Cancer National Program Group

  • All health professionals within Australia who work with lung cancer patients have access to platforms to up skill and be educated on advances and develop networks within the lung cancer arena
  • LFA established as the primary source of educational material specific to lung and thoracic cancer which meets the needs of health professionals, patients, carers, and family members
  • Advocate for early detection of lung cancer

Lung Cancer Network Australia

  • Promote, provide and coordinate services for the support and welfare of persons touched by lung cancer, whatever their culture, language, location or economic situation
  • Improve patients quality of life through access to disease-specific supportive care services
  • Raise awareness of and funds for lung cancer – early diagnosis, symptom awareness, reducing stigma

For more information visit www.lungcancernetwork.com

Australia and New Zealand Lung Cancer Nurses Forum

  • Improving patient care, health care delivery and outcomes for lung cancer patients, their families and carers. This network provides an opportunity for debate, education and knowledge transfer throughout the continuum of treatment.

For more information visit http://www.anzlcnf.com.au

Upcoming Events

28 August 2017 12.00am TACT Board Teleconference (closed)
8 September 2017 12.00am ESMO 2017 Congress, Madrid Spain
6 October 2017 12.00am ***UPDATED*** 3rd ALTG Preceptorship in Lung Cancer, Melbourne VIC
15 October 2017 12.00am TACT General Assembly (closed), Yokohama Japan
15 October 2017 12.00am 18th WCLC, Yokohama Japan
24 November 2017 12.00am ***UPDATED*** 2017 ALTG Lung Cancer Symposium, Sydney NSW
24 November 2017 12.00am ***UPDATED*** ALTG Members’ Meeting, Sydney NSW